TP53 and cancer: To exploit the combination of RAS and P53 mutations in PC, as well as in other cancers, we constructed a modified p14ARF promoter that is selectively and specifically activated by constitutively activated mut Ras (K-, H- and N-Ras) and inhibited by wt p53.